MASH Clinical Trials

Nov 09 2025
Convention Center: Hall A (General Session), Concourse Level
2:00 PM - 3:30 PM

World Class Speakers

Mary E. Rinella, MD, FAASLD
Moderator

Mary E. Rinella, MD, FAASLD

The University of Chicago
Jörn M Schattenberg, MD
Moderator

Jörn M Schattenberg, MD

Saarland University Medical Center Homburg

Journey Maps

Objectives

  • Present new efficacy and safety data from recent MASH clinical trials, highlighting potential therapeutic advances.
  • Analyze key secondary outcomes and subgroup findings to understand implications for patient selection and the effect on clinical trials.